Luk H. Vandenberghe, Ph.D.

Luk H. Vandenberghe, Ph.D.

Harvard University

H-index: 60

North America-United States

About Luk H. Vandenberghe, Ph.D.

Luk H. Vandenberghe, Ph.D., With an exceptional h-index of 60 and a recent h-index of 49 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Gene Therapy, AAV, Virology, COVID-19, Vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

Verfahren zur erhöhung der funktion eines aav-vektors

Methods of delivering an agent to the eye

Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses

Method of Increasing the Function of an AAV Vector

Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate

Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model

Simian adenoviruses SAdV-43,-45,-46,-47,-48,-49, and-50, and uses thereof

Luk H. Vandenberghe, Ph.D. Information

University

Position

Grousbeck Family Chair in Gene Therapy Associate Professor of Ophthalmology

Citations(all)

15737

Citations(since 2020)

8134

Cited By

10456

hIndex(all)

60

hIndex(since 2020)

49

i10Index(all)

119

i10Index(since 2020)

111

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Luk H. Vandenberghe, Ph.D. Skills & Research Interests

Gene Therapy

AAV

Virology

COVID-19

Vaccines

Top articles of Luk H. Vandenberghe, Ph.D.

Title

Journal

Author(s)

Publication Date

Verfahren zur erhöhung der funktion eines aav-vektors

2024/2/15

Methods of delivering an agent to the eye

2021/7/1

Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses

2024/4/16

Method of Increasing the Function of an AAV Vector

2023/12/28

Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav

2024/2/22

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate

Molecular Therapy-Methods & Clinical Development

Prashant Kumar

Michael Wang

Ozan S Kumru

John M Hickey

Julio Sanmiguel

...

2023/9/14

Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model

Molecular Therapy-Nucleic Acids

Ying Hsu

Sajag Bhattarai

Jacob M Thompson

Angela Mahoney

Jacintha Thomas

...

2023/3/14

Simian adenoviruses SAdV-43,-45,-46,-47,-48,-49, and-50, and uses thereof

2023/11/7

Altering tissue tropism of adeno-associated viruses

2023/2/16

High efficiency purification of divergent aav serotypes using aavx affinity chromatography

Molecular Therapy Methods & Clinical Development

Michael Florea

Fotini Nicolaou

Simon Pacouret

Eric M Zinn

Julio Sanmiguel

...

2023/3/9

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice

Nature medicine

Daniel Reichart

Gregory A Newby

Hiroko Wakimoto

Mingyue Lun

Joshua M Gorham

...

2023/2

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

2023/9/26

Methods of predicting ancestral virus sequences and uses thereof

2023/9/14

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid

Cell Reports Medicine

Eric Zinn

Carmen Unzu

Pauline F Schmit

Heikki T Turunen

Nerea Zabaleta

...

2022/11/15

AAVCOVID: A single-dose, thermostable COVID-19 vaccine with durable immunogenicity

Topics in Antiviral Medicine

Nerea Zabaleta

U Bhatt

C Herate

P Maisonnasse

JA Chichester

...

2022

Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes

EMBO molecular medicine

Sophia Grotz

Jessica Schäfer

Kirsten A Wunderlich

Zdenka Ellederova

Hannah Auch

...

2022/4/7

METHODS AND COMPOSITIONS FOR IMPROVING THE ASSEMBLY OF ADENO-ASSOCIATED VIRUSES (AAVs)

2022/6/16

Gene therapy with a synthetic adeno-associated viral vector improves audiovestibular phenotypes in Pjvk-mutant mice

JCI insight

Ying-Chang Lu

Yi-Hsiu Tsai

Yen-Huei Chan

Chin-Ju Hu

Chun-Ying Huang

...

2022/10/10

Single-Dose Optimized AAV-Based COVID-19 Vaccine Elicits Durable and Protective Immunity Against Variants of Concern in Nonhuman Primates

Molecular Therapy

N Zabaleta

U Bhatt

C Herate

P Maisonnasse

JA Chichester

...

2022

Pretreatment with IVIG Reduces Peripheral Transduction of AAV9 Delivered to the CNS

Cara West

Bryan Mastis

Luk H Vandenberghe

Laura K Richman

Roberto Calcedo

2022/4/1

See List of Professors in Luk H. Vandenberghe, Ph.D. University(Harvard University)

Co-Authors

H-index: 202
George Church

George Church

Harvard University

H-index: 122
Christopher S. Chen, M.D., Ph.D.

Christopher S. Chen, M.D., Ph.D.

Boston University

H-index: 82
zeger debyser

zeger debyser

Katholieke Universiteit Leuven

H-index: 80
Jim Riley

Jim Riley

University of Pennsylvania

H-index: 69
Veerle Baekelandt

Veerle Baekelandt

Katholieke Universiteit Leuven

H-index: 23
Sergey Kryazhimskiy

Sergey Kryazhimskiy

University of California, San Diego

academic-engine